Russell Flannery, Forbes Staff

Author's posts

Tech, Healthcare Companies Lead New Forbes China Up-And-Comers List

China’s healthcare industry is getting a boost from the pandemic and longer term aging in China

China Drug Maker’s Shares Plunge On AstraZeneca Vaccine “Pause”

AstraZeneca has been considered to be a global leader in the race to develop a COVID-19 vaccine.

Cancer Fight Shows Way For U.S., China To Cool Off, Collaborate: Kevin Rudd

The U.S. and China should look to their success in the fight against cancer as a way forward in their relations, the former Australia prime minister suggests.

How COVID-19 Hit Memorial Sloan Kettering, A Top U.S. Cancer Center

Philanthropy is helping to save lives, absorb costs and advance treatment

How Int’l Collaboration Is Helping To Win A War Greater Than The COVID-19 Pandemic

Cancer will kill newly three quarters of a million people worldwide this year.

Memorial Sloan Kettering, Genentech, Jiahui Health To Join Forbes China Health Summit On Aug. 15

Approximately three million people will die from cancer in China this year alone

China Cancer Diagnostics Firm Genetron’s Revenue Gains After IPO

China accounts for more than 26% of the world’s cancer deaths.

U.S. Health Chief Arrives In Taiwan At Nadir In Washington-Beijing Ties

U.S. Health and Human Services Secretary Alex Azar today became the most senior U.S. official to visit Taiwan in more than four decades.

China Drug Maker’s Shares Soar On COVID-19 Vaccine Pact With AstraZeneca

Shares among leading China pharmaceutical makers have soared amid the COVID-19 pandemic.

Billionaire Businesswomen Tops Ranking Of China’s Richest In Healthcare

COVID-19-related business has helped to lift the fortunes of leading China drug entrepreneurs.